Effect of pharmacotherapy on course of postoperative period after endovenous thermal ablation

Stoiko Yu.M., Mazaishvili K.V., Khlevtova T.V., Tsyplyashchuk A.V., Kharitonova S.E., Akimov S.S.

National Medical Surgical Centre named after N.I. Pirogov, Moscow, Russia

The authors assessed the effect of a micronized purified flavonoid fraction (MPFF) on the course of the postoperative period after endovenous thermal ablation (EVTA).

The patients of the Study Group matching by the main studied parameters to the Control Group patients were given the MPFF according to the suggested regimen for 7 days. The obtained results were analysed by means of questionnaires (CIVIQ, VCSS, VAS) and ultrasound angioscanning. The obtained findings were statistically processed by means of the program Statistica 6.0 and reliability of the results was assessed with the help of the Student t-test.

Patients of the both groups showed complete stable obliteration of the target veins. No statistically significant differences of the items of the questionnaires CIVIQ and VCSS at the beginning of the study and at the last examination were revealed, differences were noted on days 2–14 after EVTA and were not statistically significant (p>0.05).

Phlebotrophic therapy in the postoperative period after EVTA helps to decrease phlebitic alterations in the coagulated vein, to improve motor activity and mental psychoemotional state of the patients.

KEY WORDS: EVTA, postoperative period, pain syndrome, pharmacotherapy, CIVIQ.

P. 81

« Back